ELLISON MARK JASON HEATH sold 3.2% of their position (610.00 shares) of OPIANT PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $12.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/31/2023ACC: 0001385508-23-000033
Other
Since Jul 2019
-610.00
Net shares
Net seller
$12.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
610.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−610.00
Price / share
$20.26
Trade value
$12.36K
% of position
3.2%
1/27/2023
19.36K→18.75K
Total
Net shares
−610.00
Net value
-$12.36K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/27/2023 | S · Sale | −610.00 | $20.26 | $12.36K | 3.2% | 19.36K | 18.75K |
| Total | −610.00 | -$12.36K | ||||||
Derivative Transactions0
No derivative transactions reported